Search results
Apr 28, 2021 · Apr 28, 2021, 6:21 AM PDT. Albert Bourla, the CEO of Pfizer. Crystal Cox/Skye Gould/Insider. Pfizer helped develop the first safe and effective coronavirus vaccine in under a year, smashing...
In January 2022, the Pfizer CEO Albert Bourla confirmed that the trial results of a fourth dose were pending until March 2022. He said that the firm was setting up a collaboration to develop an anti-COVID pill treatment along with a French company, Novasep .
Dr. Bourla is a Doctor of Veterinary Medicine and holds a Ph.D. in the Biotechnology of Reproduction from the Veterinary School of Aristotle University. In 2021, he was named CEO of the Year by CNN Business, included in Insider Magazine’s Most Transformative CEOs list and inducted into the Crain’s New York Business 2021 Hall of Fame.
Nov 9, 2021 · November 9, 2021. Albert Bourla became CEO of Pfizer in 2019 – the pinnacle of a career at Pfizer spanning more than two decades, multiple continents and several different business functions. When he took the helm of the global pharmaceutical company, he accelerated a transformation to become a more science-driven, innovative company.
May 4, 2021 · Read the full transcript of Pfizer CEO Albert Bourla's interview with CNBC's The Exchange, where he discusses the Covid-19 vaccine, booster shots, and more.
Aug 13, 2021 · Pfizer chief Albert Bourla: ‘We are the most efficient vaccine machine’. The pharma boss on the Covid jab, his exchanges with Trump — and why suspending patents is no way to inoculate the...
Dec 1, 2021 · Albert Bourla, Pfizer’s Dean of Vaccines. The company and its German partner, BioNTech, struck more than $36 billion in deals this year for their Covid-19 vaccine, making it the bestselling ...
